Data sources Randomised controlled trials (RCTs) comparing high-intensity statin therapy (atorvastatin 80 mg or rosuvastatin 20/40 mg) with moderate/mild statin treatment or placebo were derived from ...

"In fact, nearly two-thirds of patients on Repatha in this trial, the vast majority of whom were already on high to moderate intensity statin therapy at baseline, experienced a reduction in plaque ...

美国心脏病学会（ACC）/美国心脏协会（AHA）和欧洲心脏病学会（ESC）均建议：对于确诊的动脉粥样硬化心血管疾病（ASCVD）患者使用高强度他汀类药物治疗，以将低密度脂蛋白胆固醇（LDL-C，俗称“坏胆固醇”）水平较基线至少降低50%。由于老年AS ...

A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...

Expert Rev Cardiovasc Ther. 2012;10(10):1329-1333.

In addition, the excess burden and clustering of other risk factors for CVD in racial/ethnic minorities will affect intensity of therapy ... and the Impact of Statin Therapy - Medscape - Dec ...

are based on a more extensive database, with more than 30 years of additional rainfall data and data from extra rainfall stations; are more accurate estimates, combining contemporary statistical ...